AUG 11, 2026 · PHASE 1 TRIAL
Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov
Phase 1 diagnostic imaging study in early recruitment with no results posted; designed to assess tracer accumulation and feasibility of detecting HER2 phenotype differences.
Reported
Planned enrollment20
PhasePhase 1
Primary outcome measureStandard uptake values (SUVs) in tumor lesi…